The Journal of Urology 2025
67 papers
The 2025 edition of The Journal of Urology includes 36 papers highlighting advancements in urological oncology, health equity, and digital health integration. Research into prostate cancer is a significant focus, with studies examining urban-rural and racial disparities in the use of intensified systemic therapies and advanced imaging like mpMRI and PET scans. Diagnostic developments include the evaluation of PSMA-PET/CT for molecular-guided nerve sparing and the use of Restriction Spectrum Imaging as a quantitative biomarker.
Technological applications are also prominent, featuring the use of generative artificial intelligence for data abstraction in kidney cancer pathology and wearable devices for perioperative home monitoring. In bladder cancer, research explores the efficacy of thermosensitive liposomal doxorubicin combined with hyperthermic intravesical chemotherapy. Molecular studies investigate senescence-associated miRNA in clear cell renal cell carcinoma to better understand the tumor immune microenvironment. Prolific contributors to this year’s volume include Jeremy Yuen-Chun Teoh, Chi-Fai Ng, and Hiten D. Patel, whose work reflects a broader trend toward precision diagnostics and the reduction of healthcare disparities.
Top Research Directions
Research directions most represented by The Journal of Urology 2025 papers.
| Calibrating Diagnostic Thresholds for Specific Populations | 1 |
| Mitigating Demographic Performance Disparities in Medical Imaging | 1 |
| Mitigating Inter-Observer Variability in Medical Diagnostics | 1 |
Top Authors
| Author | Papers |
|---|---|
| Jeremy Yuen-Chun Teoh | 10 |
| Alex Qinyang Liu | 4 |
| Bradford J Wood | 2 |
| Anobel Odisho | 1 |
| Jens Kleesiek | 1 |
| Qi Dou | 1 |
Papers
« prev Page 2/2